1Weller P. F and Bubley G. J. The idiopathic hypereosinophilic syndrone[J]. Blood, 1994, (83) : 2759-2779.
2陈文彬,潘祥林.诊断学[M].6版.北京:人民卫生出版社,2005.160.
3Klion AD,Noel P,Akin C,et al. Elevated serum tryptase levels i- dentify a subset of patients with a myeloproliferative variant of id- iopathic hypereosinophilic syndrone associated with tissue fibro sis, poor prognosis, and imatinib responsiveness[J ]. Blood, 2003, 101:4660-4666.
4Roufosse F,Cogan E and Goldman M. Recent advances in patho-genesis and management of hypereosinophilie syndrone[J]. Aller- gy, 2004,59 : 673-689.
5Cools J, DeAngelo DJ, Gotlib J,et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrone[J]. N Engl J Med, 2003,348 : 1201-1214.
6Butterfield JH,Gleieh GJ. Interferon alpha treatment of six pa- tients with the idiopathic hypereosinophilic syndrone[J]. Ann In- tern Med,1994,121:648-653.
